Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study.

Fields, Jerel Adam; Swinton, Mary; Sundermann, Erin E; Scrivens, Nicholas; Vallee, Kaylie-Anna Juliette; Moore, David J

Fields, Jerel Adam; Swinton, Mary; Sundermann, Erin E; Scrivens, Nicholas; Vallee, Kaylie-Anna Juliette; Moore, David J.

Afiliación

Fields JA; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Swinton M; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Sundermann EE; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Scrivens N; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Vallee KJ; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Moore DJ; Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.

Front Aging Neurosci ; 14: 981937, 2022.

Article en En | MEDLINE | ID: mdl-36118688

Palabras clave

Alzheimer's disease; HIV; betaamyloid peptide; complement component 3; complement factor H; complementimmunological term

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Aging Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google